Join
Live feed
·
INSIDERFilingvia Quantisnow
Lexaria Bioscience Corp. logo

Chief Executive Officer Christopher Richard bought $13,641 worth of shares (15,000 units at $0.91), increasing direct ownership by 30% to 65,000 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LEXX· Lexaria Bioscience Corp.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LEXX (Lexaria Bioscience Corp.) and more on Quantisnow.